期刊文献+

A型肉毒毒素改善面部动力性皱纹的近期效果观察 被引量:9

Short-Term Effect Observation of Botulinum Toxin Type A for the Treatment of Hyperkinetic Line of the Face
下载PDF
导出
摘要 目的 探讨应用A型肉毒毒素治疗面部动力性皱纹的特点及效果评价.方法 2012年11月至2013年6月,78例面部皱纹患者,均为女性,年龄27~46岁,应用A型肉毒毒素进行面部除皱,包括额纹48例,鱼尾纹30例.注射前及注射后1、3、6、9个月分别照相,比较面部皱纹变化情况,结合患者自我感觉等指标,综合分析A型肉毒毒素注射除皱的近期效果.结果 所有78例患者术后随访9个月,医患双方就术后效果共同进行评价,注射部位皱纹消除明显,患者对治疗效果满意.结论 应用A型肉毒毒素治疗面部动力性皱纹,疗效良好,安全方便,副作用少,术后满意度高. Objective To determine the efficacy of Botulinum toxin type A (BTA) for the treatment of hyperkinetic lines of the face. Methods A total of 78 patients who received BTA injection to remove facial wrinkles from December 2012 to June 2013 were enrolled. All of 78 patients were females and the age of the patients ranged from 27 to 46 years. The treatment was done in two different sessions and divided into 2 treatment subgroups of forehead (48), crow's feet (30). The short-term efficacy of BTA was analyzed at the injection day and 1 month, 3 months, 6 months and 9 months after injection. Efficacy was evaluated by contrast of photo difference, measuring changes of facial wrinkles and patient self-evaluation between pre-operation and post- operation. Results All the patients were followed up for a period of 9 months and graded for the response to treatment with BTA by the operator, observer and the patient independently using the facial wrinkle scale (FWS). These cases who received BTA injection had significant improvement in the skin around the eye status and forehead,The results of applying BTA for the treatment of hyperkinetic lines of the face were satisfactory. Conclusion BTA is characterized with a high successful rate and rare complication. It is an ideal method for the treatment of hyperkinetic lines of the face.
出处 《组织工程与重建外科杂志》 2014年第5期274-276,共3页 Journal of Tissue Engineering and Reconstructive Surgery
关键词 A型肉毒毒素 注射治疗 动力性皱纹 面部 Botulinum Toxin A Injection Treatment Hyperkinetic lines Face
  • 相关文献

参考文献12

  • 1Poungvarin N,Viriyavejakul A.Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin injection[J].J Med Assoc Thai,1992,75(4):199-203.
  • 2Klien AW.Dilution and storage of botulinum toxin[J].Dermtol Surg,1998,24:1179-1180.
  • 3Fujikawa R,Muroi Y,Unno T,et al.Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice[J].J Toxicol Sci,2010,35(6):795-805.
  • 4Carruthers JA,Lowe N J,Menter A,et al.Double blind,placebo:controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines[J].Plast Reconstr Surg,2003,112:1089-1098.
  • 5Carruthers A,Carruthers J,Cohen J.A prospective,double-blind,randomized,parallel-group,dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides[J].Dermatol Surg,2003,29(5):461-467.
  • 6Fagien S.Botox for the treatment of dynamic and hyperkinetic facial lines and furrows:adjunctive use facial aesthetic surgery[J].Plast Reconstr Surg,1999,103(2):701-713.
  • 7Niamtu Joseph Ⅲ.Botulinum toxin A:a review of 1 085 oral and maxillofacial patients treatments[J].J Oral Maxillofac Surg,2003,61:317-324.
  • 8Flynn TC,Carruthers JA,Caruthers J.Surgical pearl:the use of the Ultra-Fine Ⅱ short needle 0.3 cc insulin syringe for botulinum toxin injections[J].J Am Acad Dermatol,2002,46(6):931-933.
  • 9Carruthers JA,Caruthers J.Clinical indications and injection technique for the cosmetic use of Botulinum A exo-toxin[J].Dermatol Surg,1998,24:1189-1194.
  • 10Matilde MS.New indications for botulinum toxin type-A in cosmetic:mouth and neck.Plast Reconstr Surg2002,110:601-613.

同被引文献63

  • 1闫炳安.A型肉毒毒素与透明质酸在面部年轻化的联合应用[C].//第18届世界美容医学大会暨第八次全国医学与美容学术年会论文集.2011:235-235.
  • 2Frevert J. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products [ J ]. Drugs R D, 2015, 15 ( 1 ):. !-9. DOI: !0.1__007!S40268-0_14-.0077-1. _.
  • 3Lakraj AA, Moghimi N, Jabbari B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins [J]. Toxins (Basel), 2013, 5 (4): 821-40. DOI: 10.5390/toxins5040821.
  • 4Chen S. Clinical uses of botulinum nenrotoxins: current indications, limitations and future developments [J]. Toxins (Basel), 2012, g (10): 913-939. DOI: 10.3390/toxins4100913.
  • 5Hong HC, Lupin M, O'Shaughnessy KF. Clinical evaluation of a microwave device for treating axillary hyperhidrosis [J]. Dermatol Surg, 2012, 38(5): 728-735. DOI: 10.1111@1524-4725.2012. 02375.x.
  • 6Nestor MS, Park H. Safety and efficacy of micro-focused ultrasound plus visualization for the treatment of axillary hyperhidrosis [ J ]. J Clin Aesthet Dermatol, 201 g, 7 ( 4 ): 14-21.
  • 7Lowe NJ, Glaser DA, Eadie N, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety [J]. J Am Acad Dermatol, 2007, 56 (4): 604- 611.
  • 8Brehmer F, Eockmann A, GrSnemeyer LL, et al. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients [J]. J Dtsch Dermatol Ges, 2015, 13 (8): 799-805. DOI: 10.1111/ddg.12623.
  • 9Icouflet M, Leux C, Fenot M, et al. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients [J 1. J Am Acad Dermatol, 2014, 70 (6): 1083-1087. DOI: 10.1016/j.jaad. 2013.12.035.
  • 10Gtileq AT. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double- blind, randomized, comparative preliminary study [J]. J Eur Acad Dermatol Venereol, 2012, 26 (3): 314-318. DOI: 10.1111/j.1468- 3083.2011.04066.x.

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部